The latest medical news on Clinical Pharmacology

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about clinical pharmacology gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
Fierce Pharma

Moderna warned that it will deliver fewer doses than previously anticipated to “a number of countries,” including the U.K. and Canada. 

Fierce Pharma

Sisterhood is at the core of Eisai’s awareness campaign for endometrial cancer. The digital and social effort "Spot Her" encourages women to not on...

Fierce Pharma

Eli Lilly is partnering with seven Olympic athletes, all with connections to health challenges, in its first-ever sponsorship of the Games. Among t...

Fierce Pharma

As concerns over cases of rare but severe blood clots among vaccinated people mounted last week, Johnson & Johnson reportedly reached out to rival ...

Fierce Pharma

Pfizer was first to market in the U.S. with its BioNTech-partnered COVID-19 vaccine, and by and large, it's avoided the safety and supply concerns ...

Fierce Pharma

Sun Pharma has cut its production of poppies in Tasmania, a result of plummeting demand for surgical pain relief during the COVID-19 pandemic. Its ...

Fierce Pharma

Sanofi laid out plans for a €400M vaccine site in Singapore. BeiGene is eyeing global filings for its Novartis-partnered PD-1 inhibitor after survi...

Pharma Times

C5 complement inhibitor approved to treat PNH in adult patients with haemolysis

Pharma Times

Drug continuously improved motor function and survival in babies after 24 months of treatment

Pharma Times

The review will include an interim analysis of efficacy and safety data from the Phase III COMET-ICE trial

Pharma Times

Multiple sclerosis treatment can now be administered subcutaneously or intravenously

FDA Daily Update

Approvals FDA Gives Full Approval for Trodelvy for Triple-Negative Breast Cancer The FDA has granted full approval for Immunomedics’ Trodelvy (saci...